Doi.org/10.1093/annonc/mdj965

Target Article

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer  ; James T Roberts Hans von der Masse Lisa Sengeløv P.F Conte Luigi Dogliotti T Oliver Malcom J M; NULL; 05/01/2006; https://doi.org/10.1093/annonc/mdj965

Reasons

Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.